Compare

Oncolytics Biotech Inc vs Rocket One Inc. vs Silo Pharma, Inc. vs Acurx Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal year	Oncolytics Biotech Inc ONCY	Rocket One Inc. RKTO	Silo Pharma, Inc. SILO	Acurx Pharmaceuticals, Inc. ACXP
Year ended	2025-12-31	2025-12-31	2025-12-31	2025-12-31
Revenue	n/a	n/a	$72.1K	n/a
Revenue growth (YoY)	n/a	n/a	0.0%	n/a
Gross margin	n/a	n/a	38.6%	n/a
Operating margin	n/a	n/a	n/m	n/a
Net margin	n/a	n/a	n/m	n/a
Net income	-$28.76M	-$12.47M	-$4.23M	-$7.97M
EPS (Diluted)	-$0.30	-$0.90	-$0.50	-$5.32
Operating cash flow	-$20.11M	-$9.80M	-$4.66M	-$6.79M
Free cash flow	-$20.12M	n/a	n/a	n/a
Cash & equivalents	$5.20M	$6.25M	$4.75M	n/a
Total assets	$7.58M	$7.60M	$7.61M	$7.69M
Total liabilities	$11.38M	$1.45M	$1.30M	$2.42M
Shareholders' equity	-$3.80M	$6.15M	$6.31M	$5.27M
Return on year-end equity	n/a	-202.7%	-67.0%	-151.2%
Shares outstanding	108.02M	15.51M	13.32M	2.35M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal year	Oncolytics Biotech Inc	Rocket One Inc.	Silo Pharma, Inc.	Acurx Pharmaceuticals, Inc.
Latest	n/a	n/a	$72.1K Ended 2025-12-31	n/a
1 year earlier	n/a	n/a	$72.1K Ended 2024-12-31	n/a
2 years earlier	n/a	n/a	$72.1K Ended 2023-12-31	n/a
3 years earlier	n/a	n/a	$72.1K Ended 2022-12-31	n/a
4 years earlier	n/a	n/a	n/a	n/a